MYC and leukemia: Mata-Greenwood et al. first demonstrated that brusatol has major antiproliferative and cytotoxic effects in several leukemia cell lines, by inducing cell differentiation and G1 cell cycle arrest through the down-regulation of c-MYC protein expression [32].